ARCHIVES

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Revised Price Equivalent to Lower Dose of Avastin

November 8, 2012

NCI Plans Research To Reduce Cancer Disparities.

June 16, 2000

Informatics: Gore Helps NCI Open CGAP Website

August 8, 1997

Stop Cancer Changes Leaders, Focus, Sends $1.6M To NCI

August 30, 1991

Society Recognizes Community Oncologists (8-page issue).

June 6, 2003

Abstracts From AACR Annual Meeting

June 4, 1976